Redirect Notice

Looks like you clickedhttps://www.businesswire.com/news/home/20200303005084/en/CORRECTING-and-REPLACING-Neuraly-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-NLY01-for-Patients-with-Parkinson’s-Disease

If you do not want to visit that page, you can close this browser tab.